References
Safi F, Beger HG, Bittner R, Buchler M, Krantzberger W: CA 19.9 and pancreatic adenocarcinoma. Cancer 57:779–783, 1986
Ritts RE, Delvillano BC, Go VLW, Herberman RB, Klug TL, Zurawski VR: Initial clinical evaluation of an immunoradiometric assay for CA 19.9 using the NCI serum bank. Int J Cancer 33:339–345, 1984
Jalanko H, Kuusela P, Roberts P, Sipporen P, Haglund C, Makela O: Comparison of a new tumor marker, CA 19.9 with alphafoetoprotein and ACE in patients with upper gastrointestinal diseases. J Clin Pathol 37:218–222, 1984
Yoshikawa T, Nishida K, Tanigawa M, Fukumoto K, Kondo M: CA 19.9 and other tumor markers in gastrointestinal malignancies. Digestion 31:67–76, 1985
Arakawa Y, Ariga H, Kano M, Matsuo Y, Honda T, Morita K: Determination and significance of a new carbohydrate antigen CA 19.9 in digestive system cancers. Jpn J Med 24:121–130, 1985
Albert MB, Steinberg WM, Henry JP: Elevated serum levels of tumor marker CA 19.9 in acute cholangitis. Dig Dis Sci 33:1223–1225, 1988
Paganuzzi M, Oretto M, Marroni P, Barone D, Conio M, Aste H, Pugliese V: CA 19.9 and CA 50 in benign and malignant pancreatic and biliary diseases. Cancer 61:2100–2108, 1988
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Benamouzig, R., Buffet, C., Fourre, C. et al. Serum levels of carbohydrate antigenic determinant (CA 19.9) in obstructive jaundice. Digest Dis Sci 34, 1640–1642 (1989). https://doi.org/10.1007/BF01537129
Issue Date:
DOI: https://doi.org/10.1007/BF01537129